Lyme Disease Treatment Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Lyme Disease Treatment  Market By Disease Type (Early Lyme disease (absence of erythema migrans), Lyme carditis, Lyme arthritis, Neurologic Lyme disease, Borrelial lymphocytosis, and Post-treatment Lyme Disease Syndrome (PTLDS)), Treatment Type (Doxycycline, Amoxicillin, Cefuroxime axetil, Ceftriaxone, and Others (azithromycin, clarithromycin, erythromycin)),  Route Of Administration (Oral, Injectable, and Topical), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

Lyme Disease Treatment Market is expected to be valued at USD 857.3 million in 2022 and is poised to grow at a significant CAGR of 8.7% over 2022–2028. Lyme disease is a bacterial infection, that can get from the bite of an infected tick. Lyme disease usually has symptoms such as a rash, fever, headache, and fatigue. Infection can spread to your joints, heart, and nervous system if it is not treated early. The growing cases of Lyme disease among people result in severe problems with joints, the neurological system, exhaustion, fever, and skin rashes. As with time rising temperatures and climate change could increase the range of deer ticks’ habitat that increases the spread of lyme disease, consequently, the lyme disease treatment market would expect to expand during the forecasted period. Apart from this, lyme disease treatment is constrained by the lack of a proper lyme disease treatment regimen and misdiagnosis. Increasing research activities to develop a more effective treatment for lyme disease like cefotaxime, azlocillin, and doxycycline medications along with the development of broad-spectrum antibiotics to treat Lyme disease which impacts the human gut microbiota to make the non-target bacteria in our bodies more resistant. These are some major factors to provide attractive growth opportunities for the global lyme disease treatment market during the forecasted period. During COVID-19, Lyme disease treatment is also hampered by the complete lockdown across various regions which disrupted the supply and demand chain of raw materials, and finished products. Furthermore, due to the virus spreading patients also didn’t go to hospitals for Lyme disease treatment. Moreover, during post-pandemic  Lyme disease treatment would expected to recover the growth and is expected to have a progressive growth rate during the forecasted period.

Lyme Disease Treatment Market

MARKET SUMMARY
-
8.7%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 8.7%
  • Largest Market– Asia Pacific
  • Fastest Growing Market– North America

Lyme Disease Treatment Market

  • The report on global lyme disease treatment market gives historical, current and future market sizes (US$ Mn) on the basis of disease type, treatment type, route of administration, distribution channel, and geography.
  • The lyme disease treatment market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • Galaxo SmithKline Plc.
  • Perrigo Company Plc.
  • Pfizer, Inc.
  • Orion Corporation
  • Novartis AG
Lyme Disease Treatment Market Dynamics

Lyme Disease Treatment is primarily driven by the increasing cases of lyme disease across worldwide. There are many factors influencing Lyme disease spread such as climate change has positively contributed to ticks’ increased range, which has rising the chance of contracting Lyme disease, especially in parts of Canada where the ticks could not have survived before. Deer ticks, for instance, are naturally active when the temperature is above, they flourish in environments with at least 85% humidity and a temperature of 45 F. Thus, rising temperatures and climate change are expected to expand the range of tick habitat and increase in a number of Lyme disease cases which increased the demand of Lyme disease treatment market over the forecasted period.


North-America Got Significant Share

Lyme Disease Treatment Market

North America Lyme disease treatment market accounted for a significant revenue share in 2021 and is expected to grow with the highest CAGR during the forecasted period due to the increasing prevalence of lyme diseases by fluctuations in climate, such as warmer climate, and wet winters. According to the Centers for Disease Control and Prevention, The U.S recorded 20,000 to 30,000 confirmed cases of Lyme disease every year. These ticks spread in the U.S. through livestock or pets and also on wildlife favors increasing the cases of Lyme disease. Furthermore, continuous research and development in medical sectors would create opportunities among key players to provide effective treatment at reasonable costs.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The lyme disease treatment market report provides granular level information about the market size, regional market share, historic market (2017-2021), and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Lyme Disease Treatment Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

Based on the route of administration, The oral segment accounts for a significant market share, and it is expected to register the highest CAGR over the forecast

Key players’ profiles in the lyme disease treatment market report are Galaxo SmithKline Plc., Perrigo Company Plc., Pfizer, Inc., Orion Corporation, Novartis AG, Mayne Pharma, Sun Pharmaceuticals Industries Inc., Lupin Pharmaceuticals, Inc., Chartwell Pharmaceuticals, and Almirall, LLC.

Increasing cases of lyme disease among a large section of people across the globe, and increasing research and development activities for proper, and cost-effective treatment.

The Asia-Pacific region possesses great investment opportunities for investors to witness the most promising growth in the future.


Report

Table Of Content

1. Executive Summary
2. Global Lyme Disease Treatment Type Market Introduction
2.1. Global Lyme Disease Treatment Type Market – Taxonomy
2.2. Global Lyme Disease Treatment Type Market –Definitions
2.2.1. Disease Type
2.2.2. Treatment Type
2.2.3. Administration Route
2.2.4. Distribution Channel
2.2.5. Region
3. Global Lyme Disease Treatment Type Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Lyme Disease Treatment Type Market Dynamic Factors – Impact Analysis
3.6. Global Lyme Disease Treatment Type Market – Competition Landscape
4. Global Lyme Disease Treatment Type Market Analysis,2017 – 2021 and Forecast, 2022 – 2028
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Lyme Disease Treatment Type Market, By Disease Type, 2017–2021and Forecast, 2022–2028 (Revenue, USD Mn)
5.1. Early Lyme disease (absence of erythema migrans)
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Lyme carditis
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Lyme arthritis
5.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. neurologic Lyme disease
5.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Borrelial lymphocytosis
5.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Post-Treatment Type Lyme Disease Syndrome (PTLDS)
5.6.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
6. Global Lyme Disease Treatment Type Market, By Treatment Type, 2017 – 2021 and Forecast, 2021 – 2027 (Revenue, USD Mn)
6.1. Doxycycline
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Amoxicillin
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Cefuroxime axetil
6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Ceftriaxone
6.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Others (azithromycin, clarithromycin, erythromycin)
6.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
7. Global Lyme Disease Treatment Type Market Forecast, By Administration Route,2017–2021and Forecast, 2022–2028 (Revenue, USD Mn)
7.1. Oral
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Injectable
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Topical
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. Global Lyme Disease Treatment Type Market Forecast, By Distribution Channel, 2017–2021and Forecast, 2022–2028 (Revenue, USD Mn)
8.1. Hospital Pharmacies
8.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Retail Pharmacies
8.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Online
8.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
9. Global Lyme Disease Treatment Type Market Forecast, By Region, 2017–2021and Forecast, 2022–2028(Revenue, USD Mn)
9.1. North America
9.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Lyme Disease Treatment Type Market – Opportunity Analysis Index, By Disease Type, Treatment Type, Administration Route, Distribution Channel, and Region, 2022 – 2028
10. North America Lyme Disease Treatment Type market analysis,2017–2021and Forecast, 2022–2028(Revenue, USD Mn)
10.1. Disease Type Analysis 2017–2021and Forecast 2022 – 2028by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Early Lyme disease (absence of erythema migrans)
10.1.2. Lyme carditis
10.1.3. Lyme arthritis
10.1.4. neurologic Lyme disease
10.1.5. Borrelial lymphocytosis
10.1.6. Post-Treatment Type Lyme Disease Syndrome (PTLDS)
10.2. Treatment Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Doxycycline
10.2.2. Amoxicillin
10.2.3. Cefuroxime axetil
10.2.4. Ceftriaxone
10.2.5. Others (azithromycin, clarithromycin, erythromycin)
10.3. Administration Route Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.3.1. Oral
10.3.2.  Injectable
10.3.3.  Topical
10.4. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Hospital Pharmacies
10.4.2.  Retail Pharmacies
10.4.3.  Online
10.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. USA
10.5.2. Canada
10.6. North America Lyme Disease Treatment Type Market – Opportunity Analysis Index, By Disease Type, Treatment Type, Administration Route, Distribution Channel, and Country, 2022 – 2028
10.7. North America Lyme Disease Treatment Type Market Dynamics – Trends
11. Europe Lyme Disease Treatment Type Market Analysis, 2017–2021and Forecast, 2022–2028(Revenue, USD Mn)
11.1. Disease Type Analysis 2017–2021and Forecast 2022 – 2028by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Early Lyme disease (absence of erythema migrans)
11.1.2. Lyme carditis
11.1.3. Lyme arthritis
11.1.4. neurologic Lyme disease
11.1.5. Borrelial lymphocytosis
11.1.6. Post-Treatment Type Lyme Disease Syndrome (PTLDS)
11.2. Treatment Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Doxycycline
11.2.2. Amoxicillin
11.2.3. Cefuroxime axetil
11.2.4. Ceftriaxone
11.2.5. Others (azithromycin, clarithromycin, erythromycin)
11.3. Administration Route Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.3.1. Oral
11.3.2.  Injectable
11.3.3.  Topical
11.4. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Hospital Pharmacies
11.4.2.  Retail Pharmacies
11.4.3.  Online
11.5. Country Analysis 2017–2021and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Poland
11.5.8. Rest of Europe
11.6. Europe Lyme Disease Treatment Type Market – Opportunity Analysis Index, By Disease Type, Treatment Type, Administration Route, Distribution Channel, and Country, 2022 – 2028
11.7. Europe Lyme Disease Treatment Type Market Dynamics – Trends
12. Asia-Pacific Lyme Disease Treatment Type Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
12.1. Disease Type Analysis 2017–2021and Forecast 2022 – 2028by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Early Lyme disease (absence of erythema migrans)
12.1.2. Lyme carditis
12.1.3. Lyme arthritis
12.1.4. neurologic Lyme disease
12.1.5. Borrelial lymphocytosis
12.1.6. Post-Treatment Type Lyme Disease Syndrome (PTLDS)
12.2. Treatment Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Doxycycline
12.2.2. Amoxicillin
12.2.3. Cefuroxime axetil
12.2.4. Ceftriaxone
12.2.5. Others (azithromycin, clarithromycin, erythromycin)
12.3. Administration Route Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.3.1. Oral
12.3.2.  Injectable
12.3.3.  Topical
12.4. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Hospital Pharmacies
12.4.2.  Retail Pharmacies
12.4.3.  Online
12.5. Country Analysis2017–2021and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Lyme Disease Treatment Type Market – Opportunity Analysis Index, By Disease Type, Treatment Type, Administration Route, Distribution Channel, and Country,2022 – 2028
12.7. Asia-Pacific Lyme Disease Treatment Type Market Dynamics – Trends
13. Latin America Lyme Disease Treatment Type Market Analysis,2017 – 2021 and Forecast, 2022–2028(Revenue, USD Mn)
13.1. Disease Type Analysis 2017–2021and Forecast 2022 – 2028by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Early Lyme disease (absence of erythema migrans)
13.1.2. Lyme carditis
13.1.3. Lyme arthritis
13.1.4. neurologic Lyme disease
13.1.5. Borrelial lymphocytosis
13.1.6. Post-Treatment Type Lyme Disease Syndrome (PTLDS)
13.2. Treatment Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Doxycycline
13.2.2. Amoxicillin
13.2.3. Cefuroxime axetil
13.2.4. Ceftriaxone
13.2.5. Others (azithromycin, clarithromycin, erythromycin)
13.3. Administration Route Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.3.1. Oral
13.3.2.  Injectable
13.3.3.  Topical
13.4. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Hospital Pharmacies
13.4.2.  Retail Pharmacies
13.4.3.  Online
13.5. Country Analysis 2017–2021and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Argentina
13.5.4. Rest of Latin America
13.6. Latin America Lyme Disease Treatment Type Market – Opportunity Analysis Index, By Disease Type, Treatment Type, Administration Route, Distribution Channel, and Country, 2022 – 2028
13.7. Latin America Lyme Disease Treatment Type Market Dynamics – Trends
14. Middle East and Africa Lyme Disease Treatment Type Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
14.1. Disease Type Analysis 2017–2021and Forecast 2022 – 2028by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Early Lyme disease (absence of erythema migrans)
14.1.2. Lyme carditis
14.1.3. Lyme arthritis
14.1.4. neurologic Lyme disease
14.1.5. Borrelial lymphocytosis
14.1.6. Post-Treatment Type Lyme Disease Syndrome (PTLDS)
14.2. Treatment Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.2.1. Doxycycline
14.2.2. Amoxicillin
14.2.3. Cefuroxime axetil
14.2.4. Ceftriaxone
14.2.5. Others (azithromycin, clarithromycin, erythromycin)
14.3. Administration Route Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.3.1. Oral
14.3.2.  Injectable
14.3.3.  Topical
14.4. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Hospital Pharmacies
14.4.2.  Retail Pharmacies
14.4.3.  Online
14.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf Cooperation Council (GCC) Countries
14.5.2. Israel
14.5.3. South Africa
14.5.4. Rest of MEA
14.6. MEA Lyme Disease Treatment Type Market – Opportunity Analysis Index, By Disease Type, Treatment Type, Administration Route, Distribution Channel, and Country, 2022 – 2028
14.7. MEA Lyme Disease Treatment Type Market Dynamics – Trends
15. Competition Landscape
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Product Type& Service Testing Types, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Galaxo SmithKline Plc.
15.2.2. Perrigo Company Plc.
15.2.3. Pfizer, Inc.
15.2.4. Orion Corporation
15.2.5. Novartis AG
15.2.6. Mayne Pharma
15.2.7. Sun Pharmaceuticals Industries Inc.
15.2.8. Lupin Pharmaceuticals, Inc.
15.2.9. Chartwell Pharmaceuticals
15.2.10. Almirall, LLC
16. Research Methodology
17. Key Assumptions and Acronyms

Report

Company Profile

  • Galaxo SmithKline Plc.
  • Perrigo Company Plc.
  • Pfizer, Inc.
  • Orion Corporation
  • Novartis AG
  • Mayne Pharma
  • Sun Pharmaceuticals Industries Inc.
  • Lupin Pharmaceuticals, Inc.
  • Chartwell Pharmaceuticals
  • Almirall, LLC

Description

Lyme Disease Treatment Market is expected to be valued at USD 857.3 million in 2022 and is poised to grow at a significant CAGR of 8.7% over 2022–2028. Lyme disease is a bacterial infection, that can get from the bite of an infected tick. Lyme disease usually has symptoms such as a rash, fever, headache, and fatigue. Infection can spread to your joints, heart, and nervous system if it is not treated early. The growing cases of Lyme disease among people result in severe problems with joints, the neurological system, exhaustion, fever, and skin rashes. As with time rising temperatures and climate change could increase the range of deer ticks’ habitat that increases the spread of lyme disease, consequently, the lyme disease treatment market would expect to expand during the forecasted period. Apart from this, lyme disease treatment is constrained by the lack of a proper lyme disease treatment regimen and misdiagnosis. Increasing research activities to develop a more effective treatment for lyme disease like cefotaxime, azlocillin, and doxycycline medications along with the development of broad-spectrum antibiotics to treat Lyme disease which impacts the human gut microbiota to make the non-target bacteria in our bodies more resistant. These are some major factors to provide attractive growth opportunities for the global lyme disease treatment market during the forecasted period. During COVID-19, Lyme disease treatment is also hampered by the complete lockdown across various regions which disrupted the supply and demand chain of raw materials, and finished products. Furthermore, due to the virus spreading patients also didn’t go to hospitals for Lyme disease treatment. Moreover, during post-pandemic  Lyme disease treatment would expected to recover the growth and is expected to have a progressive growth rate during the forecasted period.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX